Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome

PLoS One. 2018 Jul 6;13(7):e0200254. doi: 10.1371/journal.pone.0200254. eCollection 2018.

Abstract

Background: Neuropsychiatric symptoms and reduced health-related quality of life (HRQoL) are frequent in multiple sclerosis, where are associated with structural brain changes, but have been less studied in clinically isolated syndrome (CIS).

Objective: To characterize HRQoL, neuropsychiatric symptoms (depressive symptoms, anxiety, apathy and fatigue), their interrelations and associations with structural brain changes in CIS.

Methods: Patients with CIS (n = 67) and demographically matched healthy controls (n = 46) underwent neurological and psychological examinations including assessment of HRQoL, neuropsychiatric symptoms and cognitive functioning, and MRI brain scan with global, regional and lesion load volume measurement.

Results: The CIS group had more, mostly mild, depressive symptoms and anxiety, and lower HRQoL physical and social subscores (p≤0.037). Neuropsychiatric symptoms were associated with most HRQoL subscores (β≤-0.34, p≤0.005). Cognitive functioning unlike clinical disability was associated with depressive symptoms and lower HRQoL emotional subscores (β≤-0.29, p≤0.019). Depressive symptoms and apathy were associated with right temporal, left insular and right occipital lesion load (ß≥0.29, p≤0.032). Anxiety was associated with lower white matter volume (ß = -0.25, p = 0.045).

Conclusion: Mild depressive symptoms and anxiety with decreased HRQoL are present in patients with CIS. Neuropsychiatric symptoms contributing to decreased HRQoL are the result of structural brain changes and require complex therapeutic approach in patients with CIS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anxiety / complications
  • Anxiety / diagnostic imaging
  • Anxiety / pathology
  • Anxiety / psychology*
  • Apathy / physiology*
  • Brain / diagnostic imaging*
  • Brain / pathology
  • Demyelinating Diseases / complications
  • Demyelinating Diseases / diagnostic imaging
  • Demyelinating Diseases / pathology
  • Demyelinating Diseases / psychology*
  • Depression / complications
  • Depression / diagnostic imaging
  • Depression / pathology
  • Depression / psychology*
  • Disability Evaluation
  • Fatigue / complications
  • Fatigue / diagnostic imaging
  • Fatigue / pathology
  • Fatigue / psychology*
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Neuropsychological Tests
  • Organ Size
  • Quality of Life*
  • Surveys and Questionnaires
  • White Matter / diagnostic imaging
  • White Matter / pathology
  • Young Adult

Grants and funding

This work received support from GAUK (Charles University Grant Agency), Grant No. 546317, http://www.cuni.cz/UK-33.html, recipient: Lukas Martinkovic; MH CZ–IGA (Ministry of Health, Czech Republic, Internal Grant Agancy) Grant Nos. NT/12385-5 and NR/9445-3, https://www.mzcr.cz/obsah/veda-a-vyzkum-iga-mz_2203_1.html, recipient: Eva Meluzinova; MH CZ–DRO (Ministry of Health, Czech Republic—conceptual development of research organization, Motol University Hospital, Prague, Czech Republic) Grant No. 00064203, https://www.mzcr.cz/dokumenty/institucionalni-podporadedikace_7615_978_3.html, recipient: Jan Laczó; and IPE (Institutional Support of Excellence, 2nd Faculty of Medicine, Charles University) Grant No. 6990122, https://www.lf2.cuni.cz/aktuality/vyhlaseni-programu-ipe-institucionalni-podpory-excelence, recipient: Jakub Hort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.